Warning Letter

Enforcement

Limiting Plant Access and Sharing Redacted Documents Results in Import Alert and Warning Letter

January 28, 2025

Enforcement

Granules India FDA 483 Includes Potential Contamination and Data Integrity Findings

November 26, 2024

Enforcement

Homeopathic Product for Infants Contaminated with Bacteria and Cancer-Causing Lubricant

July 23, 2024

Conference Spotlight

We Received a 483 After an FDA Inspection – Now What?

May 23, 2024

Conference Spotlight

Infusion Product with TNTC Bioburden Released to the Market

May 20, 2024

Conference Spotlight

FDA Post-Warning Letter Meetings are Not Agency Consultations

September 25, 2023

Enforcement

Expert Commentary: FY2022 Report on the State of Pharmaceutical Quality

June 29, 2023

Conference Spotlight

Senior Management Failures Lead to Patient Deaths, Prison Sentence

October 25, 2022

Conference Spotlight

Who Decides if my FDA Inspection is Classified OAI?

September 29, 2022

What Are Medical Device Design Controls? A Complete 2025 Guide

August 9, 2022

Conference Spotlight

From Data Integrity to Data Culture

July 21, 2022

All tags